The manufacturer of an abortion pill has petitioned the U.S. Supreme Court to examine whether a federal appeals court erred in upholding a preliminary injunction that would curtail mail-order access to the drug.
In a submission made on Friday, Danco Laboratories, the producer of the abortion pill mifepristone, requested the Supreme Court to review a Fifth Circuit Court of Appeals ruling that could potentially limit access to the drug.
